W. Mark Lafranconi - Concepedia

Author

W. Mark Lafranconi

University of Arizona

Also Known As

W M Lafranconi, W. M. Lafranconi, W. Mark Lafranconi, W.M. Lafranconi, W.Mark Lafranconi

Publications

307

Citations

H-Index

Concepts

All Affiliations

University of Arizona Arizona Science Center Johannes Gutenberg University Mainz

About

W. Mark Lafranconi is an author at University of Arizona specializing in medicine, pharmacology, and toxicology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	225
2	Biochemistry	3	3	65
3	Health Sciences	1	1	81
4	Natural Sciences	1	1	27
5	Cell Biology	1	1	16

W. Mark Lafranconi

Publications

290

Citations

H-Index

Page 1

	Year	Citations
Hepatic metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung W. Mark Lafranconi, Ryan J. Huxtable Biochemical Pharmacology HepatologyMedicineLiver PhysiologyPhysiologyHepatic Metabolism	1984	81
Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver. Pablo Steinberg, W. Mark Lafranconi, C. Roland Wolf, Molecular Pharmacology	1987	65
Xenobiotic metabolizing enzymes of rat liver nonparenchymal cells W. Mark Lafranconi, Hansruedi Glatt, Franz Oesch Toxicology and Applied Pharmacology BiochemistryNatural SciencesLiver PhysiologyHepatotoxicityMetabolism	1986	27
Chronic toxicity and carcinogenicity of olestra in Swiss CD-1 mice W. Mark Lafranconi, Philip H. Long, John E. Atkinson, Food and Chemical Toxicology Knockout MouseSwiss Cd-1 MiceMedicineOncogenic AgentCell Death	1994	26
The action of equinatoxin, a peptide from the venom of the sea anemone, Actinia equina, on the isolated lung W. Mark Lafranconi, Igor Ferlan, Findlay E. Russell, Toxicon ToxinologySea AnemoneMedicineIsolated LungPhysiology	1984	26
Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline W. Mark Lafranconi, Seitaro Ohkuma, Ryan J. Huxtable Toxicon Novel Pneumotoxic MetabolitesBiochemistryMedicineSecondary MetabolitePyrrolizidine Alkaloid	1985	21
Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline. W. Mark Lafranconi, Ryan J. Huxtable Thorax Molecular PharmacologyMonocrotaline-treated AnimalsAngiotensin-converting Enzyme ActivityPharmacological StudyBiochemistry	1983	17
Rapid Isolation of Type II Pneumocytes with Magnetic Removal of Macrophages W. Mark Lafranconi, Richard D. Spall, I. Glenn Sipes, Experimental Lung Research Tissue EngineeringInflammatory Lung DiseaseLung InflammationMagnetic RemovalImmunology	1983	16
Differentiation of the cardiac and pulmonary toxicity of monocrotaline, a pyrrolizidine alkaloid W. Mark Lafranconi, Raymond C. Duhamel, Klaus Brendel, Biochemical Pharmacology Heart FailureMedicinePhysiologyPyrrolizidine AlkaloidToxicology	1984	11

Page 1